Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

L. Kappos; R. Gold; D. H. Miller; D.G. MacManus; E. Havrdova; V. Limmroth; C.H. Polman; K. Schmierer; T.A. Yousry; M.H. Yang; M. Eraksoy; E. Meluzinova; I. Rektor; K.T. Dawson; A.W. Sandrock; G.N. O'Neill

doi:https://doi.org/10.1016/S0140-6736(08)61619-0

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

L. Kappos, R. Gold, D. H. Miller, D.G. MacManus, E. Havrdova, V. Limmroth, C.H. Polman, K. Schmierer, T.A. Yousry, M.H. Yang, M. Eraksoy, E. Meluzinova, I. Rektor, K.T. Dawson, A.W. Sandrock, G.N. O'Neill

Neurology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

442 Citations (Scopus)

Original language	English
Pages (from-to)	1463-1472
Journal	Lancet
Volume	372
Issue number	9648
DOIs	https://doi.org/10.1016/S0140-6736(08)61619-0
Publication status	Published - 2008

Access to Document

https://doi.org/10.1016/S0140-6736(08)61619-0

Cite this

Kappos, L., Gold, R., Miller, D. H., MacManus, D. G., Havrdova, E., Limmroth, V., Polman, C. H., Schmierer, K., Yousry, T. A., Yang, M. H., Eraksoy, M., Meluzinova, E., Rektor, I., Dawson, K. T., Sandrock, A. W., & O'Neill, G. N. (2008). Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet, 372(9648), 1463-1472. https://doi.org/10.1016/S0140-6736(08)61619-0

@article{1a7cdff3d6d0404cb0a8acaf196fd960,

title = "Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study",

author = "L. Kappos and R. Gold and Miller, {D. H.} and D.G. MacManus and E. Havrdova and V. Limmroth and C.H. Polman and K. Schmierer and T.A. Yousry and M.H. Yang and M. Eraksoy and E. Meluzinova and I. Rektor and K.T. Dawson and A.W. Sandrock and G.N. O'Neill",

year = "2008",

doi = "https://doi.org/10.1016/S0140-6736(08)61619-0",

language = "English",

volume = "372",

pages = "1463--1472",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9648",

}

Kappos, L, Gold, R, Miller, DH, MacManus, DG, Havrdova, E, Limmroth, V, Polman, CH, Schmierer, K, Yousry, TA, Yang, MH, Eraksoy, M, Meluzinova, E, Rektor, I, Dawson, KT, Sandrock, AW & O'Neill, GN 2008, 'Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study', Lancet, vol. 372, no. 9648, pp. 1463-1472. https://doi.org/10.1016/S0140-6736(08)61619-0

TY - JOUR

T1 - Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

AU - Kappos, L.

AU - Gold, R.

AU - Miller, D. H.

AU - MacManus, D.G.

AU - Havrdova, E.

AU - Limmroth, V.

AU - Polman, C.H.

AU - Schmierer, K.

AU - Yousry, T.A.

AU - Yang, M.H.

AU - Eraksoy, M.

AU - Meluzinova, E.

AU - Rektor, I.

AU - Dawson, K.T.

AU - Sandrock, A.W.

AU - O'Neill, G.N.

PY - 2008

Y1 - 2008

U2 - https://doi.org/10.1016/S0140-6736(08)61619-0

DO - https://doi.org/10.1016/S0140-6736(08)61619-0

M3 - Article

SN - 0140-6736

VL - 372

SP - 1463

EP - 1472

JO - Lancet

JF - Lancet

IS - 9648

ER -